ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CRVS Corvus Pharmaceuticals Inc

1.71
0.10 (6.21%)
Última actualización: 11:20:02
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Corvus Pharmaceuticals Inc CRVS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.10 6.21% 1.71 11:20:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.76 1.68 1.7799 1.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202407:30GLOBECorvus Pharmaceuticals Announces Pricing of $30.6 Million..
09/4/202415:01GLOBECorvus Pharmaceuticals Announces Initiation of..
19/3/202415:02GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
19/3/202406:27IHMARKETNEWSUS Index Futures Decline Ahead of Federal Reserve Meeting,..
13/3/202415:02GLOBECorvus Pharmaceuticals to Provide Business Update and Fourth..
01/3/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202407:30GLOBECorvus Pharmaceuticals Presents Soquelitinib Preclinical..
08/2/202415:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/2/202415:05GLOBECorvus Pharmaceuticals Announces Orphan Drug Designation..
06/2/202415:05GLOBECorvus Pharmaceuticals Appoints Jeffrey Arcara as Chief..
23/1/202416:00EDGAR2Form 8-K - Current report
23/1/202416:00GLOBECorvus Pharmaceuticals Announces the Passing of Board Member..
09/12/202311:00GLOBECorvus Pharmaceuticals Presents New Interim Soquelitinib..
08/12/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:03EDGAR2Form 8-K - Current report
07/11/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
02/11/202308:15GLOBECorvus Pharmaceuticals to Present New Interim Soquelitinib..
01/11/202318:31GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
31/10/202315:02GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
06/9/202315:05GLOBECorvus Pharmaceuticals Confirms Planned Initiation of..
08/8/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:01EDGAR2Form 8-K - Current report
08/8/202315:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..
01/8/202307:30GLOBECorvus Pharmaceuticals to Provide Business Update and Report..
06/7/202311:59GLOBECorvus Pharmaceuticals Announces Publication of Preclinical..
29/6/202306:00GLOBECorvus Pharmaceuticals Presents New Ciforadenant Preclinical..
15/6/202306:00GLOBECorvus Pharmaceuticals Presents New CPI-818 Interim Data at..
31/5/202307:30GLOBECorvus Pharmaceuticals to Present at the Jefferies..
17/5/202308:00GLOBECorvus Pharmaceuticals to Present New CPI-818 Data at the..
08/5/202315:01GLOBECorvus Pharmaceuticals Provides Business Update and Reports..

Su Consulta Reciente

Delayed Upgrade Clock